(TTAM) Titan America - Ratings and Ratios
Cement, Ready-Mix, Aggregates, Block
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.68% |
| Yield on Cost 5y | 0.72% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | 12.1% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 37.8% |
| Value at Risk 5%th | 61.7% |
| Relative Tail Risk | -0.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.27 |
| Alpha | -15.76 |
| CAGR/Max DD | 0.20 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.371 |
| Beta | 1.181 |
| Beta Downside | 1.187 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.37% |
| Mean DD | 12.19% |
| Median DD | 11.18% |
Description: TTAM Titan America November 10, 2025
Titan America SA (NYSE:TTAM), a subsidiary of Titan Cement International, manufactures and supplies a full suite of heavy building materials-including cement, ready-mix concrete, aggregates, fly ash, and concrete blocks-to construction firms, ready-mix producers, industrial customers, and the public sector across the United States. The firm also offers ancillary services such as insurance brokerage, real-estate holding, trading, transportation brokerage, and engineering sales.
Key industry signals that could affect TTAM’s outlook include: (1) U.S. construction spending is projected to grow ~3.5% YoY in 2025, driven by robust infrastructure legislation; (2) Cement capacity utilization in the U.S. hovers around 78%, leaving room for demand-driven margin expansion; and (3) TTAM reported a 2023 EBITDA margin of ~14% and a market-cap of roughly $1.2 bn, indicating solid profitability relative to peers. The company’s diversified service lines provide a hedge against cyclical downturns in core cement demand.
For a deeper, data-rich assessment of TTAM’s valuation and risk profile, you may find ValueRay’s analytical dashboard a useful next step.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (178.5m TTM) > 0 and > 6% of Revenue (6% = 98.9m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA -2.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 23.67% (prev 1.90%; Δ 21.77pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 263.8m > Net Income 178.5m (YES >=105%, WARN >=100%) |
| Net Debt (268.8m) to EBITDA (287.9m) ratio: 0.93 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.95 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (184.4m) change vs 12m ago 0.02% (target <= -2.0% for YES) |
| Gross Margin 25.93% (prev 25.12%; Δ 0.81pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 96.99% (prev 106.2%; Δ -9.22pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.70 (EBITDA TTM 287.9m / Interest Expense TTM 23.9m) >= 6 (WARN >= 3) |
Altman Z'' 4.48
| (A) 0.21 = (Total Current Assets 590.0m - Total Current Liabilities 199.9m) / Total Assets 1.85b |
| (B) 0.32 = Retained Earnings (Balance) 597.3m / Total Assets 1.85b |
| (C) 0.12 = EBIT TTM 208.1m / Avg Total Assets 1.70b |
| (D) 1.16 = Book Value of Equity 994.6m / Total Liabilities 856.8m |
| Total Rating: 4.48 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 80.27
| 1. Piotroski 6.0pt |
| 2. FCF Yield 3.51% |
| 3. FCF Margin 7.13% |
| 4. Debt/Equity 0.47 |
| 5. Debt/Ebitda 0.93 |
| 6. ROIC - WACC (= 17.04)% |
| 7. RoE 19.80% |
| 8. Rev. Trend 40.04% |
| 9. EPS Trend 86.66% |
What is the price of TTAM shares?
Over the past week, the price has changed by +5.39%, over one month by +10.74%, over three months by +18.87% and over the past year by +6.29%.
Is TTAM a buy, sell or hold?
- Strong Buy: 4
- Buy: 0
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the TTAM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17 | -3.5% |
| Analysts Target Price | 17 | -3.5% |
| ValueRay Target Price | 18 | 2% |
TTAM Fundamental Data Overview January 04, 2026
P/S = 1.869
P/B = 3.0548
Beta = None
Revenue TTM = 1.65b USD
EBIT TTM = 208.1m USD
EBITDA TTM = 287.9m USD
Long Term Debt = 390.1m USD (from longTermDebt, last quarter)
Short Term Debt = 17.5m USD (from shortTermDebt, last quarter)
Debt = 464.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 268.8m USD (from netDebt column, last quarter)
Enterprise Value = 3.35b USD (3.08b + Debt 464.5m - CCE 195.6m)
Interest Coverage Ratio = 8.70 (Ebit TTM 208.1m / Interest Expense TTM 23.9m)
EV/FCF = 28.49x (Enterprise Value 3.35b / FCF TTM 117.6m)
FCF Yield = 3.51% (FCF TTM 117.6m / Enterprise Value 3.35b)
FCF Margin = 7.13% (FCF TTM 117.6m / Revenue TTM 1.65b)
Net Margin = 10.83% (Net Income TTM 178.5m / Revenue TTM 1.65b)
Gross Margin = 25.93% ((Revenue TTM 1.65b - Cost of Revenue TTM 1.22b) / Revenue TTM)
Gross Margin QoQ = 29.22% (prev 26.25%)
Tobins Q-Ratio = 1.81 (Enterprise Value 3.35b / Total Assets 1.85b)
Interest Expense / Debt = 1.17% (Interest Expense 5.44m / Debt 464.5m)
Taxrate = 26.70% (20.9m / 78.3m)
NOPAT = 152.5m (EBIT 208.1m * (1 - 26.70%))
Current Ratio = 2.95 (Total Current Assets 590.0m / Total Current Liabilities 199.9m)
Debt / Equity = 0.47 (Debt 464.5m / totalStockholderEquity, last quarter 994.6m)
Debt / EBITDA = 0.93 (Net Debt 268.8m / EBITDA 287.9m)
Debt / FCF = 2.29 (Net Debt 268.8m / FCF TTM 117.6m)
Total Stockholder Equity = 901.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.50% (Net Income 178.5m / Total Assets 1.85b)
RoE = 19.80% (Net Income TTM 178.5m / Total Stockholder Equity 901.3m)
RoCE = 16.11% (EBIT 208.1m / Capital Employed (Equity 901.3m + L.T.Debt 390.1m))
RoIC = 26.07% (NOPAT 152.5m / Invested Capital 585.0m)
WACC = 9.04% (E(3.08b)/V(3.55b) * Re(10.27%) + D(464.5m)/V(3.55b) * Rd(1.17%) * (1-Tc(0.27)))
Discount Rate = 10.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 71.68% ; FCFF base≈127.2m ; Y1≈109.4m ; Y5≈85.8m
Fair Price DCF = 5.61 (EV 1.30b - Net Debt 268.8m = Equity 1.03b / Shares 184.4m; r=9.04% [WACC]; 5y FCF grow -16.95% → 2.90% )
EPS Correlation: 86.66 | EPS CAGR: 68.08% | SUE: N/A | # QB: 0
Revenue Correlation: 40.04 | Revenue CAGR: 5.29% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.24 | Chg30d=+0.035 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=1.23 | Chg30d=-0.018 | Revisions Net=-2 | Growth EPS=+15.8% | Growth Revenue=+6.4%
Additional Sources for TTAM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle